MEN2A-RET-induced cellular transformation by activation of STAT3
- PMID: 11536047
- DOI: 10.1038/sj.onc.1204715
MEN2A-RET-induced cellular transformation by activation of STAT3
Abstract
The MEN2A oncogene encodes for a constitutive active member of the RET receptor tyrosine kinase family. Here, we report that MEN2A-RET activates Signal Transducer and Activator of Transcription 3 (STAT3) via two YxxV/Q STAT3 docking sites, Tyr752 and Tyr928. MEN2A-RET induces both Tyr705 and Ser727 phosphorylation of STAT3, and STAT3 serine phosphorylation is required for its maximal transcriptional activity. Stable NIH3T3 cell lines expressing both MEN2A-RET and STAT3alpha but not STAT3beta, are characterized by enhanced proliferation and cyclin-D1 promoter activity, and enhanced growth in soft agar. These data indicate that malignant cell growth induced by MEN2A-RET involves its activation of STAT3.
Similar articles
-
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.Cancer Res. 2001 Feb 15;61(4):1426-31. Cancer Res. 2001. PMID: 11245446
-
RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor.Cancer Res. 2005 Mar 1;65(5):1729-37. doi: 10.1158/0008-5472.CAN-04-2363. Cancer Res. 2005. PMID: 15753368
-
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival.Cancer Res. 2000 Jul 15;60(14):3727-31. Cancer Res. 2000. PMID: 10919641
-
Molecular mechanism of activation and superactivation of Ret tyrosine kinases by ultraviolet light irradiation.Antioxid Redox Signal. 2000 Winter;2(4):841-9. doi: 10.1089/ars.2000.2.4-841. Antioxid Redox Signal. 2000. PMID: 11213488 Review.
-
[From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].Ned Tijdschr Geneeskd. 2001 Nov 17;145(46):2217-21. Ned Tijdschr Geneeskd. 2001. PMID: 11757244 Review. Dutch.
Cited by
-
RET-Altered Cancers-A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity.Cancers (Basel). 2023 Aug 17;15(16):4146. doi: 10.3390/cancers15164146. Cancers (Basel). 2023. PMID: 37627175 Free PMC article. Review.
-
Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes.Cancers (Basel). 2023 Apr 5;15(7):2163. doi: 10.3390/cancers15072163. Cancers (Basel). 2023. PMID: 37046823 Free PMC article.
-
FOXA2 and STAT5A regulate oncogenic activity of KIF5B-RET fusion.Am J Cancer Res. 2023 Feb 15;13(2):638-653. eCollection 2023. Am J Cancer Res. 2023. PMID: 36895965 Free PMC article.
-
RET signaling pathway and RET inhibitors in human cancer.Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022. Front Oncol. 2022. PMID: 35957881 Free PMC article. Review.
-
Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.J Med Chem. 2021 Aug 26;64(16):11747-11773. doi: 10.1021/acs.jmedchem.0c02167. Epub 2021 Aug 17. J Med Chem. 2021. PMID: 34402300 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
